a company which engages in the research and development of biopharmaceutical products
Industry Biotechnology
A.I.dvisor indicates that over the last year, RNA has been loosely correlated with DYN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RNA jumps, then DYN could also see price increases.
Ticker / NAME | Correlation To RNA | 1D Price Change % | ||
---|---|---|---|---|
RNA | 100% | +12.35% | ||
DYN - RNA | 48% Loosely correlated | +16.37% | ||
SWTX - RNA | 41% Loosely correlated | +4.86% | ||
RCUS - RNA | 41% Loosely correlated | -2.03% | ||
ACLX - RNA | 39% Loosely correlated | -0.34% | ||
RXRX - RNA | 38% Loosely correlated | -3.43% | ||
More |
Ticker / NAME | Correlation To RNA | 1D Price Change % |
---|---|---|
RNA | 100% | +12.35% |
medicine theme (3 stocks) | 92% Closely correlated | -0.75% |
biopharmaceutical theme (10 stocks) | 77% Closely correlated | -2.76% |
cancer theme (82 stocks) | 45% Loosely correlated | -2.38% |
treatment theme (56 stocks) | 39% Loosely correlated | -1.12% |
diseases theme (41 stocks) | 37% Loosely correlated | -1.18% |